Travere Therapeutics, Inc. (TVTX) compared with its closest peers (NATR, MIRM, ORGO, INVA, CPRX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Nature's Sunshine Products, Mirum Pharmaceuticals, Organogenesis, Innoviva, Catalyst Pharmaceuticals, Ardelyx, Esperion Therapeutics, Insmed, OPKO Health and Axsome Therapeutics share Travere Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Nature's Sunshine Products, Inc. (NATR) | $252.32M | 13.2 |
| Mirum Pharmaceuticals, Inc. (MIRM) | $5.87B | -168.0 |
| Organogenesis Holdings Inc. (ORGO) | $231.61M | 34.5 |
| Innoviva, Inc. (INVA) | $1.52B | 4.0 |
| Catalyst Pharmaceuticals, Inc. (CPRX) | $3.85B | 17.1 |
| Ardelyx, Inc. (ARDX) | $968.09M | -22.4 |
| Esperion Therapeutics, Inc. (ESPR) | $821.21M | -33.7 |
| Insmed Incorporated (INSM) | $27.47B | -27.1 |
| OPKO Health, Inc. (OPK) | $1.10B | -4.2 |
| Axsome Therapeutics, Inc. (AXSM) | $10.88B | -49.7 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
TVTX overview · TVTX earnings · TVTX financials · TVTX KPIs · TVTX documents · TVTX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.